TreeWAS – Variant ID: rs6456703

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E83.1 Disorders of iron metabolism	0.000	0.000	1.000
K90.0 Coeliac disease	1.000	0.000	0.000
E03.9 Hypothyroidism, unspecified	0.897	0.103	0.000
E03 Other hypothyroidism	0.890	0.110	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.888	0.112	0.000
E00-E07 Disorders of thyroid gland	0.888	0.112	0.000
E05.9 Thyrotoxicosis, unspecified	0.874	0.126	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.836	0.164	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.761	0.239	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.725	0.275	0.000
E20-E35 Disorders of other endocrine glands	0.725	0.275	0.000
E10-E14 Diabetes mellitus	0.710	0.290	0.000
E27 Other disorders of adrenal gland	0.703	0.297	0.000
E10 Insulin-dependent diabetes mellitus	0.697	0.303	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.693	0.307	0.000
E10.9 Without complications	0.689	0.311	0.000
K90 Intestinal malabsorption	0.686	0.314	0.000
E07 Other disorders of thyroid	0.685	0.315	0.000
E05.8 Other thyrotoxicosis	0.683	0.317	0.000
E27.1 Primary adrenocortical insufficiency	0.649	0.351	0.000
E16 Other disorders of pancreatic internal secretion	0.644	0.356	0.000
E03.5 Myxoedema coma	0.638	0.362	0.000
E03.4 Atrophy of thyroid (acquired)	0.638	0.362	0.000
E03.3 Postinfectious hypothyroidism	0.638	0.362	0.000
E03.1 Congenital hypothyroidism without goitre	0.638	0.362	0.000
E03.0 Congenital hypothyroidism with diffuse goitre	0.638	0.362	0.000
E05.5 Thyroid crisis or storm	0.637	0.363	0.000
E05.4 Thyrotoxicosis factitia	0.637	0.363	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.637	0.363	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.637	0.363	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.636	0.363	0.000
E00 Congenital iodine-deficiency syndrome	0.636	0.363	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.636	0.364	0.000
E22 Hyperfunction of pituitary gland	0.633	0.367	0.000
E23 Hypofunction and other disorders of pituitary gland	0.626	0.374	0.000
E16.2 Hypoglycaemia, unspecified	0.621	0.379	0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.620	0.380	0.000
E07.8 Other specified disorders of thyroid	0.612	0.388	0.000
E04 Other non-toxic goitre	0.581	0.419	0.000
E27.2 Addisonian crisis	0.579	0.421	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.579	0.421	0.000
E10.5 With peripheral circulatory complications	0.571	0.429	0.000
E10.2 With renal complications	0.570	0.430	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.563	0.437	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.561	0.439	0.000
E50-E64 Other nutritional deficiencies	0.559	0.441	0.000
E22.1 Hyperprolactinaemia	0.558	0.442	0.000
E34 Other endocrine disorders	0.554	0.446	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.546	0.454	0.000
E10.7 With multiple complications	0.540	0.460	0.000
E03.8 Other specified hypothyroidism	0.534	0.466	0.000
E20 Hypoparathyroidism	0.531	0.469	0.000
E10.8 With unspecified complications	0.529	0.471	0.000
E04.9 Non-toxic goitre, unspecified	0.529	0.471	0.000
K90.9 Intestinal malabsorption, unspecified	0.528	0.472	0.000
E23.7 Disorder of pituitary gland, unspecified	0.526	0.474	0.000
E27.9 Disorder of adrenal gland, unspecified	0.523	0.477	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.520	0.480	0.000
E32 Diseases of thymus	0.520	0.480	0.000
E31 Polyglandular dysfunction	0.520	0.480	0.000
E30 Disorders of puberty, not elsewhere classified	0.520	0.480	0.000
E23.2 Diabetes insipidus	0.518	0.482	0.000
E14 Unspecified diabetes mellitus	0.513	0.487	0.000
E13 Other specified diabetes mellitus	0.510	0.490	0.000
E12 Malnutrition-related diabetes mellitus	0.509	0.491	0.000
E23.6 Other disorders of pituitary gland	0.505	0.495	0.000
E27.5 Adrenomedullary hyperfunction	0.504	0.496	0.000
E27.0 Other adrenocortical overactivity	0.504	0.496	0.000
E25 Adrenogenital disorders	0.503	0.497	0.000
E10.0 With coma	0.502	0.498	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.497	0.503	0.000
E15 Nondiabetic hypoglycaemic coma	0.497	0.503	0.000
E34.9 Endocrine disorder, unspecified	0.493	0.507	0.000
E10.6 With other specified complications	0.492	0.508	0.000
K90.3 Pancreatic steatorrhoea	0.492	0.508	0.000
K90.2 Blind loop syndrome, not elsewhere classified	0.492	0.508	0.000
K90.1 Tropical sprue	0.492	0.508	0.000
E07.1 Dyshormogenetic goitre	0.491	0.509	0.000
E07.0 Hypersecretion of calcitonin	0.491	0.509	0.000
E27.8 Other specified disorders of adrenal gland	0.473	0.527	0.000
E10.3 With ophthalmic complications	0.473	0.527	0.000
E26 Hyperaldosteronism	0.471	0.529	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.462	0.538	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.462	0.538	0.000
E16.4 Abnormal secretion of gastrin	0.462	0.538	0.000
E16.3 Increased secretion of glucagon	0.462	0.538	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.456	0.543	0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.456	0.543	0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.456	0.543	0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.456	0.543	0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.456	0.543	0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.456	0.543	0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.456	0.543	0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.456	0.543	0.000
E16.1 Other hypoglycaemia	0.455	0.545	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.454	0.546	0.000
E22.8 Other hyperfunction of pituitary gland	0.454	0.546	0.000
E14.3 With ophthalmic complications	0.451	0.549	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.449	0.551	0.000
E23.1 Drug-induced hypopituitarism	0.449	0.551	0.000
E24 Cushing's syndrome	0.444	0.555	0.000
E61 Deficiency of other nutrient elements	0.443	0.557	0.000
E06 Thyroiditis	0.441	0.558	0.000
K90.8 Other intestinal malabsorption	0.438	0.562	0.000
E14.5 With peripheral circulatory complications	0.425	0.575	0.000
E40-E46 Malnutrition	0.420	0.580	0.000
E51 Thiamine deficiency	0.417	0.583	0.000
E04.8 Other specified non-toxic goitre	0.417	0.583	0.000
E55 Vitamin D deficiency	0.416	0.584	0.000
E14.6 With other specified complications	0.406	0.594	0.000
E64 Sequelae of malnutrition and other nutritional deficiencies	0.401	0.599	0.000
E63 Other nutritional deficiencies	0.401	0.599	0.000
E56 Other vitamin deficiencies	0.401	0.599	0.000
E50 Vitamin A deficiency	0.401	0.599	0.000
E60 Dietary zinc deficiency	0.401	0.599	0.000
E59 Dietary selenium deficiency	0.401	0.599	0.000
E54 Ascorbic acid deficiency	0.401	0.599	0.000
E52 Niacin deficiency [pellagra]	0.401	0.599	0.000
E58 Dietary calcium deficiency	0.399	0.601	0.000
E34.5 Androgen resistance syndrome	0.397	0.603	0.000
E34.4 Constitutional tall stature	0.397	0.603	0.000
E34.3 Short stature, not elsewhere classified	0.397	0.603	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.397	0.603	0.000
E34.1 Other hypersecretion of intestinal hormones	0.397	0.603	0.000
E14.1 With ketoacidosis	0.392	0.608	0.000
E20.9 Hypoparathyroidism, unspecified	0.392	0.608	0.000
E13.3 With ophthalmic complications	0.389	0.611	0.000
E61.1 Iron deficiency	0.387	0.613	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.383	0.617	0.000
E04.0 Non-toxic diffuse goitre	0.383	0.617	0.000
E20.8 Other hypoparathyroidism	0.381	0.619	0.000
E20.1 Pseudohypoparathyroidism	0.381	0.619	0.000
E20.0 Idiopathic hypoparathyroidism	0.381	0.619	0.000
E21.4 Other specified disorders of parathyroid gland	0.379	0.621	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.374	0.626	0.000
E30.9 Disorder of puberty, unspecified	0.373	0.627	0.000
E30.8 Other disorders of puberty	0.373	0.627	0.000
E30.1 Precocious puberty	0.373	0.627	0.000
E30.0 Delayed puberty	0.373	0.627	0.000
E31.9 Polyglandular dysfunction, unspecified	0.373	0.627	0.000
E31.8 Other polyglandular dysfunction	0.373	0.627	0.000
E31.1 Polyglandular hyperfunction	0.373	0.627	0.000
E31.0 Autoimmune polyglandular failure	0.373	0.627	0.000
E32.9 Disease of thymus, unspecified	0.373	0.627	0.000
E32.8 Other diseases of thymus	0.373	0.627	0.000
E32.1 Abscess of thymus	0.373	0.627	0.000
E32.0 Persistent hyperplasia of thymus	0.373	0.627	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.373	0.627	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.373	0.627	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.373	0.627	0.000
E10.1 With ketoacidosis	0.372	0.628	0.000
E04.1 Non-toxic single thyroid nodule	0.370	0.630	0.000
E14.7 With multiple complications	0.368	0.632	0.000
E14.0 With coma	0.368	0.632	0.000
E13.8 With unspecified complications	0.366	0.634	0.000
E13.7 With multiple complications	0.366	0.634	0.000
E13.6 With other specified complications	0.366	0.634	0.000
E13.5 With peripheral circulatory complications	0.366	0.634	0.000
E13.4 With neurological complications	0.366	0.634	0.000
E13.2 With renal complications	0.366	0.634	0.000
E13.1 With ketoacidosis	0.366	0.634	0.000
E13.0 With coma	0.366	0.634	0.000
E12.9 Without complications	0.365	0.635	0.000
E12.8 With unspecified complications	0.365	0.635	0.000
E12.7 With multiple complications	0.365	0.635	0.000
E12.6 With other specified complications	0.365	0.635	0.000
E12.5 With peripheral circulatory complications	0.365	0.635	0.000
E12.4 With neurological complications	0.365	0.635	0.000
E12.3 With ophthalmic complications	0.365	0.635	0.000
E12.2 With renal complications	0.365	0.635	0.000
E12.1 With ketoacidosis	0.365	0.635	0.000
E12.0 With coma	0.365	0.635	0.000
E25.9 Adrenogenital disorder, unspecified	0.361	0.639	0.000
E25.8 Other adrenogenital disorders	0.361	0.639	0.000
E28 Ovarian dysfunction	0.360	0.640	0.000
E21.3 Hyperparathyroidism, unspecified	0.360	0.640	0.000
E21.2 Other hyperparathyroidism	0.357	0.643	0.000
E34.0 Carcinoid syndrome	0.353	0.647	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.344	0.656	0.000
E21.0 Primary hyperparathyroidism	0.342	0.658	0.000
E13.9 Without complications	0.341	0.659	0.000
E14.8 With unspecified complications	0.340	0.660	0.000
E24.2 Drug-induced Cushing's syndrome	0.338	0.662	0.000
E26.9 Hyperaldosteronism, unspecified	0.337	0.662	0.000
E26.8 Other hyperaldosteronism	0.337	0.662	0.000
E26.1 Secondary hyperaldosteronism	0.337	0.662	0.000
E29 Testicular dysfunction	0.335	0.663	0.002
E10.4 With neurological complications	0.332	0.668	0.000
E14.2 Withrenal complications	0.329	0.671	0.000
E23.0 Hypopituitarism	0.321	0.679	0.000
E24.8 Other Cushing's syndrome	0.319	0.681	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.319	0.681	0.000
E24.3 Ectopic ACTH syndrome	0.319	0.681	0.000
E24.1 Nelson's syndrome	0.319	0.681	0.000
E61.9 Deficiency of nutrient element, unspecified	0.318	0.682	0.000
E61.8 Deficiency of other specified nutrient elements	0.318	0.682	0.000
E61.7 Deficiency of multiple nutrient elements	0.318	0.682	0.000
E61.6 Vanadium deficiency	0.318	0.682	0.000
E61.5 Molybdenum deficiency	0.318	0.682	0.000
E61.4 Chromium deficiency	0.318	0.682	0.000
E61.3 Manganese deficiency	0.318	0.682	0.000
E61.0 Copper deficiency	0.318	0.682	0.000
E53 Deficiency of other B group vitamins	0.317	0.683	0.000
E06.5 Other chronic thyroiditis	0.316	0.683	0.000
E06.4 Drug-induced thyroiditis	0.316	0.683	0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.316	0.683	0.000
E06.1 Subacute thyroiditis	0.316	0.683	0.000
E06.0 Acute thyroiditis	0.316	0.683	0.000
E51.2 Wernicke's encephalopathy	0.315	0.685	0.000
E55.9 Vitamin D deficiency, unspecified	0.313	0.687	0.000
E34.8 Other specified endocrine disorders	0.308	0.692	0.000
E65-E68 Obesity and other hyperalimentation	0.307	0.693	0.000
E44 Protein-energy malnutrition of moderate and mild degree	0.301	0.698	0.000
E45 Retarded development following protein-energy malnutrition	0.301	0.698	0.000
E43 Unspecified severe protein-energy malnutrition	0.301	0.698	0.000
E42 Marasmic kwashiorkor	0.301	0.698	0.000
E41 Nutritional marasmus	0.301	0.698	0.000
E40 Kwashiorkor	0.301	0.698	0.000
E07.9 Disorder of thyroid, unspecified	0.299	0.700	0.000
E51.9 Thiamine deficiency, unspecified	0.299	0.701	0.000
E51.8 Other manifestations of thiamine deficiency	0.299	0.701	0.000
E51.1 Beriberi	0.299	0.701	0.000
E14.4 With neurological complications	0.298	0.702	0.000
E55.0 Rickets, active	0.298	0.702	0.000
E24.0 Pituitary-dependent Cushing's disease	0.295	0.705	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.292	0.708	0.000
N32.0 Bladder-neck obstruction	0.000	0.708	0.292
E26.0 Primary hyperaldosteronism	0.288	0.711	0.000
E50.9 Vitamin A deficiency, unspecified	0.287	0.712	0.000
E50.8 Other manifestations of vitamin A deficiency	0.287	0.712	0.000
E50.7 Other ocular manifestations of vitamin A deficiency	0.287	0.712	0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.287	0.712	0.000
E50.5 Vitamin A deficiency with night blindness	0.287	0.712	0.000
E50.4 Vitamin A deficiency with keratomalacia	0.287	0.712	0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.287	0.712	0.000
E50.2 Vitamin A deficiency with corneal xerosis	0.287	0.712	0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.287	0.712	0.000
E50.0 Vitamin A deficiency with conjunctival xerosis	0.287	0.712	0.000
E56.9 Vitamin deficiency, unspecified	0.287	0.712	0.000
E56.8 Deficiency of other vitamins	0.287	0.712	0.000
E56.1 Deficiency of vitamin K	0.287	0.712	0.000
E56.0 Deficiency of vitamin E	0.287	0.712	0.000
E63.9 Nutritional deficiency, unspecified	0.287	0.712	0.000
E63.8 Other specified nutritional deficiencies	0.287	0.712	0.000
E63.1 Imbalance of constituents of food intake	0.287	0.712	0.000
E63.0 Essential fatty acid [EFA] deficiency	0.287	0.712	0.000
E64.9 Sequelae of unspecified nutritional deficiency	0.287	0.712	0.000
E64.8 Sequelae of other nutritional deficiencies	0.287	0.712	0.000
E64.3 Sequelae of rickets	0.287	0.712	0.000
E64.2 Sequelae of vitamin C deficiency	0.287	0.712	0.000
E64.1 Sequelae of vitamin A deficiency	0.287	0.712	0.000
E64.0 Sequelae of protein-energy malnutrition	0.287	0.712	0.000
N32 Other disorders of bladder	0.000	0.735	0.265
N32.8 Other specified disorders of bladder	0.000	0.740	0.260
E28.9 Ovarian dysfunction, unspecified	0.258	0.742	0.000
E28.8 Other ovarian dysfunction	0.258	0.742	0.000
E28.1 Androgen excess	0.258	0.742	0.000
E28.0 Oestrogen excess	0.258	0.742	0.000
E61.2 Magnesium deficiency	0.258	0.742	0.000
D64.9 Anaemia, unspecified	0.248	0.752	0.000
E06.9 Thyroiditis, unspecified	0.247	0.753	0.000
E53.9 Vitamin B deficiency, unspecified	0.247	0.753	0.000
E24.9 Cushing's syndrome, unspecified	0.244	0.755	0.000
E22.0 Acromegaly and pituitary gigantism	0.243	0.756	0.001
E29.9 Testicular dysfunction, unspecified	0.240	0.758	0.002
E29.8 Other testicular dysfunction	0.240	0.758	0.002
E29.0 Testicular hyperfunction	0.240	0.758	0.002
E06.3 Autoimmune thyroiditis	0.236	0.764	0.000
E28.3 Primary ovarian failure	0.229	0.771	0.000
E53.1 Pyridoxine deficiency	0.228	0.772	0.000
E53.0 Riboflavin deficiency	0.228	0.772	0.000
E67 Other hyperalimentation	0.220	0.780	0.000
E68 Sequelae of hyperalimentation	0.220	0.780	0.000
E44.1 Mild protein-energy malnutrition	0.216	0.784	0.000
E44.0 Moderate protein-energy malnutrition	0.216	0.784	0.000
N30-N39 Other diseases of urinary system	0.000	0.785	0.215
N39 Other disorders of urinary system	0.000	0.804	0.196
N39.8 Other specified disorders of urinary system	0.000	0.804	0.196
N31 Neuromuscular dysfunction of bladder, not elsewhere classified	0.000	0.808	0.192
N32.4 Rupture of bladder, nontraumatic	0.000	0.809	0.190
N34 Urethritis and urethral syndrome	0.000	0.812	0.188
N39.9 Disorder of urinary system, unspecified	0.000	0.819	0.181
N31.8 Other neuromuscular dysfunction of bladder	0.000	0.822	0.178
E46 Unspecified protein-energy malnutrition	0.176	0.824	0.000
N32.1 Vesicointestinal fistula	0.000	0.825	0.175
N32.2 Vesical fistula, not elsewhere classified	0.000	0.826	0.174
N34.2 Other urethritis	0.000	0.829	0.171
N32.3 Diverticulum of bladder	0.000	0.835	0.165
D64 Other anaemias	0.163	0.837	0.000
E67.8 Other specified hyperalimentation	0.158	0.842	0.000
E67.3 Hypervitaminosis D	0.158	0.842	0.000
E67.2 Megavitamin-B6 syndrome	0.158	0.842	0.000
E67.1 Hypercarotenaemia	0.158	0.842	0.000
E67.0 Hypervitaminosis A	0.158	0.842	0.000
E28.2 Polycystic ovarian syndrome	0.156	0.843	0.000
N30 Cystitis	0.000	0.845	0.155
N37 Urethral disorders in diseases classified elsewhere	0.000	0.846	0.154
N33 Bladder disorders in diseases classified elsewhere	0.000	0.846	0.154
E65 Localised adiposity	0.154	0.846	0.000
N31.9 Neuromuscular dysfunction of bladder, unspecified	0.000	0.849	0.151
N30.3 Trigonitis	0.000	0.850	0.150
E11 Non-insulin-dependent diabetes mellitus	0.148	0.852	0.000
E83 Disorders of mineral metabolism	0.101	0.858	0.041
N39.2 Orthostatic proteinuria, unspecified	0.000	0.859	0.141
E04.2 Non-toxic multinodular goitre	0.140	0.860	0.000
N34.1 Nonspecific urethritis	0.000	0.861	0.139
N31.1 Reflex neuropathic bladder, not elsewhere classified	0.000	0.862	0.138
N31.0 Uninhibited neuropathic bladder, not elsewhere classified	0.000	0.862	0.138
N34.0 Urethral abscess	0.000	0.865	0.135
D64.3 Other sideroblastic anaemias	0.133	0.867	0.000
E11.5 With peripheral circulatory complications	0.130	0.870	0.000
N30.0 Acute cystitis	0.000	0.871	0.129
D64.0 Hereditary sideroblastic anaemia	0.129	0.871	0.000
N34.3 Urethral syndrome, unspecified	0.000	0.872	0.128
N39.1 Persistent proteinuria, unspecified	0.000	0.872	0.128
N39.0 Urinary tract infection, site not specified	0.000	0.874	0.126
D64.8 Other specified anaemias	0.123	0.877	0.000
N36 Other disorders of urethra	0.000	0.878	0.122
E66 Obesity	0.122	0.878	0.000
E14.9 Without complications	0.121	0.879	0.000
O46.9 Antepartum haemorrhage, unspecified	0.120	0.880	0.000
N30.4 Irradiation cystitis	0.000	0.881	0.119
N30.1 Interstitial cystitis (chronic)	0.000	0.883	0.117
D64.4 Congenital dyserythropoietic anaemia	0.117	0.883	0.000
D64.2 Secondary sideroblastic anaemia due to drugs and toxins	0.117	0.883	0.000
D64.1 Secondary sideroblastic anaemia due to disease	0.117	0.883	0.000
E70-E90 Metabolic disorders	0.116	0.884	0.000
E11.1 With ketoacidosis	0.114	0.886	0.000
N33.8 Bladder disorders in other diseases classified elsewhere	0.000	0.889	0.111
N33.0 Tuberculous cystitis	0.000	0.889	0.111
N37.8 Other urethral disorders in diseases classified elsewhere	0.000	0.889	0.111
N37.0 Urethritis in diseases classified elsewhere	0.000	0.889	0.111
E11.6 With other specified complications	0.110	0.889	0.000
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.000	0.893	0.107
E11.7 With multiple complications	0.106	0.893	0.000
E11.2 With renal complications	0.105	0.895	0.000
E11.0 With coma	0.105	0.895	0.000
N36.1 Urethral diverticulum	0.000	0.897	0.103
O46 Antepartum haemorrhage, not elsewhere classified	0.102	0.898	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.102	0.898	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.072	0.898	0.030
E83.8 Other disorders of mineral metabolism	0.072	0.898	0.030
E83.2 Disorders of zinc metabolism	0.072	0.898	0.030
E83.0 Disorders of copper metabolism	0.072	0.898	0.030
N32.9 Bladder disorder, unspecified	0.000	0.899	0.101
E66.8 Other obesity	0.101	0.899	0.000
N36.2 Urethral caruncle	0.000	0.901	0.099
E53.8 Deficiency of other specified B group vitamins	0.098	0.902	0.000
E83.5 Disorders of calcium metabolism	0.095	0.903	0.001
J84.1 Other interstitial pulmonary diseases with fibrosis	0.096	0.904	0.000
E80.4 Gilbert's syndrome	0.092	0.908	0.000
E79 Disorders of purine and pyrimidine metabolism	0.089	0.911	0.000
E83.3 Disorders of phosphorus metabolism	0.069	0.912	0.019
E66.1 Drug-induced obesity	0.087	0.912	0.000
O46.8 Other antepartum haemorrhage	0.087	0.913	0.000
N36.0 Urethral fistula	0.000	0.913	0.087
E73 Lactose intolerance	0.086	0.914	0.000
N35 Urethral stricture	0.000	0.916	0.084
E77 Disorders of glycoprotein metabolism	0.083	0.916	0.000
E76 Disorders of glycosaminoglycan metabolism	0.083	0.916	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.083	0.916	0.000
E72 Other disorders of amino-acid metabolism	0.083	0.916	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.083	0.916	0.000
E70 Disorders of aromatic amino-acid metabolism	0.083	0.916	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.083	0.916	0.000
N36.3 Prolapsed urethral mucosa	0.000	0.917	0.083
E84 Cystic fibrosis	0.082	0.918	0.000
E66.2 Extreme obesity with alveolar hypoventilation	0.081	0.919	0.000
O44.1 Placenta praevia with haemorrhage	0.079	0.921	0.000
O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems	0.077	0.923	0.000
O36 Maternal care for other known or suspected foetal problems	0.077	0.923	0.000
O44 Placenta praevia	0.077	0.923	0.000
N36.9 Urethral disorder, unspecified	0.000	0.925	0.075
E80.2 Other porphyria	0.074	0.926	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.074	0.926	0.000
O46.0 Antepartum haemorrhage with coagulation defect	0.073	0.927	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.073	0.927	0.000
E80.6 Other disorders of bilirubin metabolism	0.073	0.927	0.000
E80.5 Crigler-Najjar syndrome	0.073	0.927	0.000
E80.3 Defects of catalase and peroxydase	0.073	0.927	0.000
E80.1 Porphyria cutanea tarda	0.073	0.927	0.000
E80.0 Hereditary erythropoietic porphyria	0.073	0.927	0.000
E83.4 Disorders of magnesium metabolism	0.059	0.928	0.013
E74 Other disorders of carbohydrate metabolism	0.070	0.929	0.000
E11.8 With unspecified complications	0.070	0.929	0.000
E66.0 Obesity due to excess calories	0.070	0.930	0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.070	0.930	0.000
J84 Other interstitial pulmonary diseases	0.068	0.932	0.000
O36.6 Maternal care for excessive foetal growth	0.067	0.933	0.000
O35 Maternal care for known or suspected foetal abnormality and damage	0.066	0.934	0.000
E89.2 Postprocedural hypoparathyroidism	0.066	0.934	0.000
O43 Placental disorders	0.066	0.934	0.000
O36.4 Maternal care for intra-uterine death	0.065	0.935	0.000
O36.8 Maternal care for other specified foetal problems	0.065	0.935	0.000
O36.9 Maternal care for foetal problem, unspecified	0.065	0.935	0.000
E73.9 Lactose intolerance, unspecified	0.064	0.935	0.000
E88 Other metabolic disorders	0.064	0.935	0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.064	0.936	0.000
E79.8 Other disorders of purine and pyrimidine metabolism	0.064	0.936	0.000
E79.1 Lesch-Nyhan syndrome	0.064	0.936	0.000
O36.0 Maternal care for rhesus isoimmunisation	0.063	0.937	0.000
E73.8 Other lactose intolerance	0.062	0.938	0.000
E73.1 Secondary lactase deficiency	0.062	0.938	0.000
E73.0 Congenital lactase deficiency	0.062	0.938	0.000
E85 Amyloidosis	0.062	0.938	0.000
J84.9 Interstitial pulmonary disease, unspecified	0.062	0.938	0.000
N35.1 Postinfective urethral stricture, not elsewhere classified	0.000	0.940	0.060
N35.0 Posttraumatic urethral stricture	0.000	0.940	0.060
E29.1 Testicular hypofunction	0.056	0.940	0.005
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.060	0.940	0.000
E70.8 Other disorders of aromatic amino-acid metabolism	0.060	0.940	0.000
E70.3 Albinism	0.060	0.940	0.000
E70.2 Disorders of tyrosine metabolism	0.060	0.940	0.000
E70.1 Other hyperphenylalaninaemias	0.060	0.940	0.000
E70.0 Classical phenylketonuria	0.060	0.940	0.000
E71.3 Disorders of fatty-acid metabolism	0.060	0.940	0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.060	0.940	0.000
E71.1 Other disorders of branched-chain amino-acid metabolism	0.060	0.940	0.000
E71.0 Maple-syrup-urine disease	0.060	0.940	0.000
E72.9 Disorder of amino-acid metabolism, unspecified	0.060	0.940	0.000
E72.8 Other specified disorders of amino-acid metabolism	0.060	0.940	0.000
E72.5 Disorders of glycine metabolism	0.060	0.940	0.000
E72.4 Disorders of ornithine metabolism	0.060	0.940	0.000
E72.3 Disorders of lysine and hydroxylysine metabolism	0.060	0.940	0.000
E72.2 Disorders of urea cycle metabolism	0.060	0.940	0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.060	0.940	0.000
E72.0 Disorders of amino-acid transport	0.060	0.940	0.000
E75.6 Lipid storage disorder, unspecified	0.060	0.940	0.000
E75.5 Other lipid storage disorders	0.060	0.940	0.000
E75.4 Neuronal ceroid lipofuscinosis	0.060	0.940	0.000
E75.3 Sphingolipidosis, unspecified	0.060	0.940	0.000
E75.2 Other sphingolipidosis	0.060	0.940	0.000
E75.1 Other gangliosidosis	0.060	0.940	0.000
E75.0 GM2 gangliosidosis	0.060	0.940	0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.060	0.940	0.000
E76.8 Other disorders of glucosaminoglycan metabolism	0.060	0.940	0.000
E76.3 Mucopolysaccharidosis, unspecified	0.060	0.940	0.000
E76.2 Other mucopolysaccharidoses	0.060	0.940	0.000
E76.1 Mucopolysaccharidosis, type II	0.060	0.940	0.000
E76.0 Mucopolysaccharidosis, type I	0.060	0.940	0.000
E77.9 Disorder of glycoprotein metabolism, unspecified	0.060	0.940	0.000
E77.8 Other disorders of glycoprotein metabolism	0.060	0.940	0.000
E77.1 Defects in glycoprotein degradation	0.060	0.940	0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.060	0.940	0.000
Z80.4 Family history of malignant neoplasm of genital organs	0.000	0.941	0.059
O43.8 Other placental disorders	0.059	0.941	0.000
E84.8 Cystic fibrosis with other manifestations	0.059	0.941	0.000
E84.1 Cystic fibrosis with intestinal manifestations	0.059	0.941	0.000
E84.0 Cystic fibrosis with pulmonary manifestations	0.059	0.941	0.000
O41 Other disorders of amniotic fluid and membranes	0.059	0.941	0.000
O31 Complications specific to multiple gestation	0.058	0.941	0.000
O33 Maternal care for known or suspected disproportion	0.058	0.942	0.000
O36.1 Maternal care for other isoimmunisation	0.058	0.942	0.000
O45 Premature separation of placenta [abruptio placentae]	0.058	0.942	0.000
E84.9 Cystic fibrosis, unspecified	0.057	0.943	0.000
N35.8 Other urethral stricture	0.000	0.943	0.056
O35.1 Maternal care for (suspected) chromosomal abnormality in foetus	0.057	0.943	0.000
E89.1 Postprocedural hypoinsulinaemia	0.056	0.943	0.000
O36.7 Maternal care for viable foetus in abdominal pregnancy	0.055	0.945	0.000
O36.2 Maternal care for hydrops foetalis	0.055	0.945	0.000
O36.3 Maternal care for signs of foetal hypoxia	0.055	0.945	0.000
N30.8 Other cystitis	0.000	0.946	0.054
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.053	0.947	0.000
E89.8 Other postprocedural endocrine and metabolic disorders	0.053	0.947	0.000
E89.5 Postprocedural testicular hypofunction	0.053	0.947	0.000
J84.0 Alveolar and parietoalveolar conditions	0.053	0.947	0.000
O44.0 Placenta praevia specified as without haemorrhage	0.052	0.948	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.052	0.948	0.000
O40 Polyhydramnios	0.052	0.948	0.000
E74.9 Disorder of carbohydrate metabolism, unspecified	0.051	0.949	0.000
E74.8 Other specified disorders of carbohydrate metabolism	0.051	0.949	0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.051	0.949	0.000
E74.2 Disorders of galactose metabolism	0.051	0.949	0.000
E74.1 Disorders of fructose metabolism	0.051	0.949	0.000
E74.0 Glycogen storage disease	0.051	0.949	0.000
O41.0 Oligohydramnios	0.051	0.949	0.000
O35.9 Maternal care for (suspected) foetal abnormality and damage, unspecified	0.051	0.949	0.000
N30.9 Cystitis, unspecified	0.000	0.949	0.051
K90-K93 Other diseases of the digestive system	0.050	0.950	0.000
O35.8 Maternal care for other (suspected) foetal abnormality and damage	0.049	0.951	0.000
E88.9 Metabolic disorder, unspecified	0.049	0.951	0.000
E89.4 Postprocedural ovarian failure	0.048	0.952	0.000
O43.9 Placental disorder, unspecified	0.048	0.952	0.000
E88.2 Lipomatosis, not elsewhere classified	0.048	0.952	0.000
E11.9 Without complications	0.048	0.952	0.000
O35.7 Maternal care for (suspected) damage to foetus by other medical procedures	0.047	0.952	0.000
O35.6 Maternal care for (suspected) damage to foetus by radiation	0.047	0.952	0.000
O35.5 Maternal care for (suspected) damage to foetus by drugs	0.047	0.952	0.000
O35.4 Maternal care for (suspected) damage to foetus from alcohol	0.047	0.952	0.000
O35.3 Maternal care for (suspected) damage to foetus from viral disease in mother	0.047	0.952	0.000
O35.2 Maternal care for (suspected) hereditary disease in foetus	0.047	0.952	0.000
O43.2 Morbidly adherent placenta	0.047	0.953	0.000
O43.0 Placental transfusion syndromes	0.047	0.953	0.000
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.047	0.953	0.000
N39.3 Stress incontinence	0.000	0.953	0.047
E88.1 Lipodystrophy, not elsewhere classified	0.046	0.953	0.000
E11.4 With neurological complications	0.046	0.953	0.000
E88.8 Other specified metabolic disorders	0.046	0.954	0.000
O35.0 Maternal care for (suspected) central nervous system malformation in foetus	0.045	0.955	0.000
O36.5 Maternal care for poor foetal growth	0.045	0.955	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations